Malin Corporation plc

Irish Stock Exchange:MLC.IR

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

💊 Pharmaceuticals

💻 Telehealth

Location

Ireland

Market Cap

USD 40.06 M

Share Price

USD 9.26

Avg Daily Volume

239,171

Change (1 day)

0.48%

Change (1 year)

46.82%

Change (YTD)

3.99%

Malin Corporation plc Free Cash Flow for the year ending December 31, 2024: USD -1.35 M

Malin Corporation plc Free Cash Flow is USD -1.35 M for the year ending December 31, 2024, a -61.89% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Malin Corporation plc Free Cash Flow for the year ending December 31, 2023 was USD -3.53 M, a -54.15% change year over year.
Malin Corporation plc Free Cash Flow for the year ending December 31, 2022 was USD -7.70 M, a 9.15% change year over year.
Malin Corporation plc Free Cash Flow for the year ending December 31, 2021 was USD -7.06 M, a 13.29% change year over year.
Malin Corporation plc Free Cash Flow for the year ending December 31, 2020 was USD -6.23 M, a -19.54% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Free Cash Flow	Operating Cash Flow	Capital Expenditure	Net Cash Used For Investing Activities

Irish Stock Exchange: MLC.IR

Malin Corporation plc

CEO	Ms. Fiona Dunlevy
IPO Date	March 25, 2014
Location	Ireland
Headquarters	The Lennox Building
Employees	2
Sector	🏥 Health Care
Industries Biotechnology 🔬 Clinical Trials 🏥 Hospitals & Clinics 💊 Pharmaceuticals 💻 Telehealth

Description

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.